About Asthmatx
Asthmatx is a company based in Sunnyvale (United States) founded in 2003 was acquired by Boston Scientific in September 2010. Asthmatx has raised $50 million across 1 funding round from investors including Boston Scientific and Olympus. Asthmatx operates in a competitive market with competitors including Nuvaira, RejuvenAir and D R Burton, among others.
- Headquarter Sunnyvale, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Asthmatx Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$50 M (USD)
in 1 rounds
-
Latest Funding Round
$50 M (USD), Series D
May 15, 2007
-
Investors
Boston Scientific
& 1 more
-
Employee Count
Not available
-
Acquired by
Boston Scientific
(Sep 20, 2010)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Asthmatx
Asthmatx has successfully raised a total of $50M through 1 strategic funding round. The most recent funding activity was a Series D round of $50 million completed in May 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Asthmatx
Asthmatx has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Boston Scientific and Olympus.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Manufacturer of imaging and surgical products
|
Locked | Locked | Locked | |
|
Wide range of medical devices
|
Locked | Locked | Locked |
Investor details for Asthmatx
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Asthmatx
Investment portfolio details for Asthmatx
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Asthmatx
Detailed financials for Asthmatx
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Asthmatx Comparisons
Peer comparison for Asthmatx
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Asthmatx
Asthmatx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nuvaira, RejuvenAir and D R Burton, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
A catheter-based system for COPD treatment is developed and provided.
|
|
| Locked | Locked | Locked |
Cryosurgical device for chronic bronchitis and COPD treatment is developed.
|
|
| Locked | Locked | Locked |
Provides comprehensive products for positive pressure therapy in lung disease patients.
|
Detailed competitors of Asthmatx
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Asthmatx
Complete news archive for Asthmatx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Asthmatx
Asthmatx was founded in 2003 and raised its 1st funding round 4 years after it was founded.
Asthmatx is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Asthmatx is a funded company, having raised a total of $50M across 1 funding round to date.
Asthmatx is a medical device company, focuses on developing and commercializing a therapeutic treatment for asthma in the United States. The company has developed a technology that is designed to deliver controlled thermal radiofrequency energy to the airways of adult patients to reduce the mass of airway smooth muscle in a procedure called Bronchial Thermoplasty. Asthmatx offers an interventional medical device, called the Alair System, for the bronchoscopic treatment of patients with moderate to severe asthma. The Alair Bronchial Thermoplasty System is indicated for the treatment of severe persistent asthma in patients 18 years and older whose asthma is not well-controlled with inhaled corticosteroids and long-acting beta-agonist medicines. Patients are treated in multiple sessions, each targeting a different section of the airways.
Asthmatx's top competitors include Nuvaira, RejuvenAir and D R Burton.
Asthmatx has 2 investors. Key investors include Boston Scientific, and Olympus.